Musculoskeletal pain is one of the most common complaints among women in perimenopause and menopause, yet it remains underrecognized and frequently mischaracterized. Women often present with shoulder pain, hip stiffness, tendon discomfort, or diffuse joint aches without a clear history of injury.
These symptoms are typically approached as isolated orthopedic conditions. However, the timing, progression and systemic nature of these presentations suggest a broader physiologic origin.
Increasing evidence supports that musculoskeletal symptoms in midlife are influenced by hormonal decline, inflammatory changes, metabolic dysfunction, and alterations in nervous system regulation. Recognizing this interconnected physiology is essential for accurate diagnosis and effective treatment.
The Hormonal Influence on Connective Tissue
Estrogen plays a central role in maintaining connective-tissue integrity. It regulates collagen synthesis, extracellular matrix turnover and tissue hydration. As estrogen levels decline during perimenopause and menopause, connective tissues become less elastic, more rigid and more vulnerable to injury.1
These changes are not localized to a single joint, but affect tendons, ligaments and fascial systems throughout the body. Clinically, this contributes to the widespread stiffness and reduced mobility commonly reported in midlife women.
Inflammation and Pain Sensitivity
Estrogen also modulates inflammatory activity. Reduced estrogen levels are associated with increased production of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), contributing to a state of low-grade systemic inflammation.2
This inflammatory shift increases tissue sensitivity and alters pain perception. Women frequently report heightened discomfort in response to previously tolerated activities, reflecting both peripheral tissue changes and central modulation of pain pathways.3
Metabolic Dysfunction & Tissue Quality
Metabolic changes during menopause, particularly increasing insulin resistance, further influence musculoskeletal health. Elevated glucose levels contribute to the formation of advanced glycation end products (AGEs), which accumulate in connective tissues and reduce elasticity.4
This process leads to stiffer, less adaptable tissues that are more prone to discomfort and injury. Additionally, reduced muscle protein synthesis and progressive loss of lean muscle mass increase mechanical stress on joints, compounding musculoskeletal symptoms.5
Nervous System Dysregulation and Recovery
Sleep disturbances are a hallmark of the menopausal transition and have a direct impact on tissue repair and pain regulation. Disrupted sleep alters cortisol rhythm, impairs recovery and increases central sensitization to pain.6
As a result, the nervous system becomes more reactive, and the body’s ability to recover from physical stress is diminished. This contributes to the cycle of persistent discomfort and delayed healing observed in many patients.
Presentation: A Systemic Pattern
While shoulder pain is a common presenting complaint, the clinical pattern extends beyond a single region. Patients frequently report:
- Hip stiffness
- Knee discomfort
- Foot pain, including plantar fasciitis
- Diffuse muscle soreness
- Prolonged recovery following exercise
These symptoms often develop concurrently and cannot be fully explained by localized structural pathology. Instead, they reflect a coordinated physiologic shift affecting multiple systems.
Clinical Case Illustration
The following case represents a typical clinical presentation observed in practice and is included for illustrative purposes.
A 52-year-old woman presented with persistent right shoulder pain previously diagnosed as adhesive capsulitis. She reported no history of trauma but noted progressive stiffness over several months.
Further evaluation revealed disrupted sleep, increased central adiposity, morning stiffness in multiple joints, and decreased tolerance to exercise.
A systems-based intervention was implemented, including nutritional strategies to stabilize blood sugar and reduce inflammation, increased protein intake to support muscle repair, sleep-focused interventions to improve nervous system regulation, and targeted manual therapy.
Over time, the patient demonstrated improved range of motion, reduced overall pain and enhanced recovery capacity.
This presentation illustrates that the shoulder was not the isolated source of dysfunction, but rather a localized manifestation of broader systemic changes.
A Systems-Based, Non-Hormonal Management Approach
Effective management of midlife musculoskeletal pain requires addressing the underlying physiologic drivers:
Nutrition and Inflammatory Regulation: Nutritional strategies that stabilize blood glucose and reduce inflammatory burden support improved tissue function and decreased pain signaling.
Protein and Muscular Support: Adequate protein intake is essential for maintaining muscle mass and supporting connective-issue repair, reducing biomechanical stress on joints.
Sleep and Nervous System Regulation: Improving sleep quality enhances hormonal signaling, reduces inflammation and restores recovery capacity.
Movement and Manual Therapy: Targeted movement and manual therapies improve joint mobility and neuromuscular coordination, but are most effective when integrated with systemic interventions.
Discussion
The traditional approach to musculoskeletal pain in midlife women often focuses on localized structural pathology. However, this model does not adequately account for the widespread and multifactorial nature of symptoms observed during the menopausal transition.
Emerging literature increasingly supports the concept of a menopause-associated musculoskeletal syndrome, characterized by the interplay of hormonal, inflammatory, metabolic, and neurologic factors.3
A systems-based framework allows clinicians to better understand symptom patterns and implement more comprehensive, non-hormonal treatment strategies.
Clinical Pearls
Musculoskeletal pain in perimenopause and menopause reflects a broader physiologic shift rather than an isolated structural problem. Declining estrogen, increased inflammation, metabolic dysfunction, and nervous system dysregulation collectively alter tissue quality, pain perception, and recovery capacity.
Recognizing this interconnected model enables clinicians to move beyond symptom management and toward more effective, systems-based care that improves long-term outcomes for midlife women.
References
- Chidi-Ogbolu N, Baar K. Effect of estrogen on musculoskeletal performance and injury risk. Front Physiol, 2019;9:1834.
- Straub RH. The complex role of estrogens in inflammation. Endocr Rev, 2007;28(5):521-574.
- Wright NC, et al. Musculoskeletal symptoms and menopause: a systematic review. Climacteric, 2024 Oct;27(5):466-472.
- Singh R, et al. Advanced glycation end-products: a review. Diabetologia, 2001;44(2):129-146.
- Greising SM, et al. Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci, 2009;64A(10):1071-1081.
- Moldofsky H. Sleep and pain. Sleep Med Rev, 2001;5(5):385-396.
